Table of Content

1 Radiopharmaceutical Market Overview
1.1 Radiopharmaceutical Product Overview
1.2 Radiopharmaceutical Market Segment by Type
1.2.1 Actinium-225
1.2.2 Lutetium-177
1.2.3 Radium-223
1.2.4 Holmium-166
1.2.5 Other
1.3 Global Radiopharmaceutical Market Size by Type
1.3.1 Global Radiopharmaceutical Market Size Overview by Type (2018-2034)
1.3.2 Global Radiopharmaceutical Historic Market Size Review by Type (2018-2024)
1.3.3 Global Radiopharmaceutical Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Radiopharmaceutical Sales Breakdown by Type (2018-2024)
1.4.2 Europe Radiopharmaceutical Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Radiopharmaceutical Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Type (2018-2024)
2 Global Radiopharmaceutical Market Competition by Company
2.1 Global Top Players by Radiopharmaceutical Sales (2018-2024)
2.2 Global Top Players by Radiopharmaceutical Revenue (2018-2024)
2.3 Global Top Players by Radiopharmaceutical Price (2018-2024)
2.4 Global Top Manufacturers Radiopharmaceutical Manufacturing Base Distribution, Sales Area, Product Type
2.5 Radiopharmaceutical Market Competitive Situation and Trends
2.5.1 Radiopharmaceutical Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceutical Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2022)
2.7 Date of Key Manufacturers Enter into Radiopharmaceutical Market
2.8 Key Manufacturers Radiopharmaceutical Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Radiopharmaceutical Status and Outlook by Region
3.1 Global Radiopharmaceutical Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Radiopharmaceutical Historic Market Size by Region
3.2.1 Global Radiopharmaceutical Sales in Volume by Region (2018-2024)
3.2.2 Global Radiopharmaceutical Sales in Value by Region (2018-2024)
3.2.3 Global Radiopharmaceutical Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Radiopharmaceutical Forecasted Market Size by Region
3.3.1 Global Radiopharmaceutical Sales in Volume by Region (2024-2034)
3.3.2 Global Radiopharmaceutical Sales in Value by Region (2024-2034)
3.3.3 Global Radiopharmaceutical Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Radiopharmaceutical by Application
4.1 Radiopharmaceutical Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Other
4.2 Global Radiopharmaceutical Market Size by Application
4.2.1 Global Radiopharmaceutical Market Size Overview by Application (2018-2034)
4.2.2 Global Radiopharmaceutical Historic Market Size Review by Application (2018-2024)
4.2.3 Global Radiopharmaceutical Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Radiopharmaceutical Sales Breakdown by Application (2018-2024)
4.3.2 Europe Radiopharmaceutical Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Radiopharmaceutical Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Application (2018-2024)
5 North America Radiopharmaceutical by Country
5.1 North America Radiopharmaceutical Historic Market Size by Country
5.1.1 North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Radiopharmaceutical Sales in Volume by Country (2018-2024)
5.1.3 North America Radiopharmaceutical Sales in Value by Country (2018-2024)
5.2 North America Radiopharmaceutical Forecasted Market Size by Country
5.2.1 North America Radiopharmaceutical Sales in Volume by Country (2024-2034)
5.2.2 North America Radiopharmaceutical Sales in Value by Country (2024-2034)
6 Europe Radiopharmaceutical by Country
6.1 Europe Radiopharmaceutical Historic Market Size by Country
6.1.1 Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Radiopharmaceutical Sales in Volume by Country (2018-2024)
6.1.3 Europe Radiopharmaceutical Sales in Value by Country (2018-2024)
6.2 Europe Radiopharmaceutical Forecasted Market Size by Country
6.2.1 Europe Radiopharmaceutical Sales in Volume by Country (2024-2034)
6.2.2 Europe Radiopharmaceutical Sales in Value by Country (2024-2034)
7 Asia-Pacific Radiopharmaceutical by Region
7.1 Asia-Pacific Radiopharmaceutical Historic Market Size by Region
7.1.1 Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Radiopharmaceutical Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Radiopharmaceutical Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Radiopharmaceutical Forecasted Market Size by Region
7.2.1 Asia-Pacific Radiopharmaceutical Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Radiopharmaceutical Sales in Value by Region (2024-2034)
8 Latin America Radiopharmaceutical by Country
8.1 Latin America Radiopharmaceutical Historic Market Size by Country
8.1.1 Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Radiopharmaceutical Sales in Volume by Country (2018-2024)
8.1.3 Latin America Radiopharmaceutical Sales in Value by Country (2018-2024)
8.2 Latin America Radiopharmaceutical Forecasted Market Size by Country
8.2.1 Latin America Radiopharmaceutical Sales in Volume by Country (2024-2034)
8.2.2 Latin America Radiopharmaceutical Sales in Value by Country (2024-2034)
9 Middle East and Africa Radiopharmaceutical by Country
9.1 Middle East and Africa Radiopharmaceutical Historic Market Size by Country
9.1.1 Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Radiopharmaceutical Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Radiopharmaceutical Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Radiopharmaceutical Forecasted Market Size by Country
9.2.1 Middle East and Africa Radiopharmaceutical Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Radiopharmaceutical Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bracco Imaging
10.1.1 Bracco Imaging Company Information
10.1.2 Bracco Imaging Introduction and Business Overview
10.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bracco Imaging Radiopharmaceutical Products Offered
10.1.5 Bracco Imaging Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer Radiopharmaceutical Products Offered
10.2.5 Bayer Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Mallinckrodt Radiopharmaceutical Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Nordion
10.4.1 Nordion Company Information
10.4.2 Nordion Introduction and Business Overview
10.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Nordion Radiopharmaceutical Products Offered
10.4.5 Nordion Recent Development
10.5 Triad Isotopes
10.5.1 Triad Isotopes Company Information
10.5.2 Triad Isotopes Introduction and Business Overview
10.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Triad Isotopes Radiopharmaceutical Products Offered
10.5.5 Triad Isotopes Recent Development
10.6 Lantheus
10.6.1 Lantheus Company Information
10.6.2 Lantheus Introduction and Business Overview
10.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Lantheus Radiopharmaceutical Products Offered
10.6.5 Lantheus Recent Development
10.7 IBA Group
10.7.1 IBA Group Company Information
10.7.2 IBA Group Introduction and Business Overview
10.7.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.7.4 IBA Group Radiopharmaceutical Products Offered
10.7.5 IBA Group Recent Development
10.8 GE Healthcare
10.8.1 GE Healthcare Company Information
10.8.2 GE Healthcare Introduction and Business Overview
10.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.8.4 GE Healthcare Radiopharmaceutical Products Offered
10.8.5 GE Healthcare Recent Development
10.9 China Isotope & Radiation
10.9.1 China Isotope & Radiation Company Information
10.9.2 China Isotope & Radiation Introduction and Business Overview
10.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.9.4 China Isotope & Radiation Radiopharmaceutical Products Offered
10.9.5 China Isotope & Radiation Recent Development
10.10 Jubilant Pharma
10.10.1 Jubilant Pharma Company Information
10.10.2 Jubilant Pharma Introduction and Business Overview
10.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Jubilant Pharma Radiopharmaceutical Products Offered
10.10.5 Jubilant Pharma Recent Development
10.11 Eli Lilly
10.11.1 Eli Lilly Company Information
10.11.2 Eli Lilly Introduction and Business Overview
10.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Eli Lilly Radiopharmaceutical Products Offered
10.11.5 Eli Lilly Recent Development
10.12 Advanced Accelerator Applications
10.12.1 Advanced Accelerator Applications Company Information
10.12.2 Advanced Accelerator Applications Introduction and Business Overview
10.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Advanced Accelerator Applications Radiopharmaceutical Products Offered
10.12.5 Advanced Accelerator Applications Recent Development
10.13 SIEMENS
10.13.1 SIEMENS Company Information
10.13.2 SIEMENS Introduction and Business Overview
10.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.13.4 SIEMENS Radiopharmaceutical Products Offered
10.13.5 SIEMENS Recent Development
10.14 Dongcheng
10.14.1 Dongcheng Company Information
10.14.2 Dongcheng Introduction and Business Overview
10.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Dongcheng Radiopharmaceutical Products Offered
10.14.5 Dongcheng Recent Development
10.15 Navidea
10.15.1 Navidea Company Information
10.15.2 Navidea Introduction and Business Overview
10.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Navidea Radiopharmaceutical Products Offered
10.15.5 Navidea Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Radiopharmaceutical Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Radiopharmaceutical Industrial Chain Analysis
11.4 Radiopharmaceutical Market Dynamics
11.4.1 Radiopharmaceutical Industry Trends
11.4.2 Radiopharmaceutical Market Drivers
11.4.3 Radiopharmaceutical Market Challenges
11.4.4 Radiopharmaceutical Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Radiopharmaceutical Distributors
12.3 Radiopharmaceutical Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Actinium-225
Table 2. Major Company of Lutetium-177
Table 3. Major Company of Radium-223
Table 4. Major Company of Holmium-166
Table 5. Major Company of Other
Table 6. Global Radiopharmaceutical Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Radiopharmaceutical Sales by Type (2018-2024) & (M Doses)
Table 8. Global Radiopharmaceutical Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Radiopharmaceutical Sales by Type (2018-2024) & (US& Million)
Table 10. Global Radiopharmaceutical Market Share in Value by Type (2018-2024)
Table 11. Global Radiopharmaceutical Price by Type (2018-2024) & (USD/Dose)
Table 12. Global Radiopharmaceutical Sales by Type (2024-2034) & (M Doses)
Table 13. Global Radiopharmaceutical Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Radiopharmaceutical Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Radiopharmaceutical Sales Market Share in Value by Type (2024-2034)
Table 16. Global Radiopharmaceutical Price by Type (2024-2034) & (USD/Dose)
Table 17. North America Radiopharmaceutical Sales by Type (2018-2024) & (M Doses)
Table 18. North America Radiopharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Radiopharmaceutical Sales (M Doses) by Type (2018-2024)
Table 20. Europe Radiopharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Radiopharmaceutical Sales (M Doses) by Type (2018-2024)
Table 22. Asia-Pacific Radiopharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Radiopharmaceutical Sales (M Doses) by Type (2018-2024)
Table 24. Latin America Radiopharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Radiopharmaceutical Sales (M Doses) by Type (2018-2024)
Table 26. Middle East and Africa Radiopharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Radiopharmaceutical Sales by Company (2018-2024) & (M Doses)
Table 28. Global Radiopharmaceutical Sales Share by Company (2018-2024)
Table 29. Global Radiopharmaceutical Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Radiopharmaceutical Revenue Share by Company (2018-2024)
Table 31. Global Market Radiopharmaceutical Price by Company (2018-2024) & (USD/Dose)
Table 32. Global Radiopharmaceutical Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2022)
Table 35. Date of Key Manufacturers Enter into Radiopharmaceutical Market
Table 36. Key Manufacturers Radiopharmaceutical Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Radiopharmaceutical Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Radiopharmaceutical Sales by Region (2018-2024) & (M Doses)
Table 40. Global Radiopharmaceutical Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Radiopharmaceutical Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Radiopharmaceutical Sales Market Share in Value by Region (2018-2024)
Table 43. Global Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 44. Global Radiopharmaceutical Sales by Region (2024-2034) & (M Doses)
Table 45. Global Radiopharmaceutical Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Radiopharmaceutical Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Radiopharmaceutical Sales Market Share in Value by Region (2024-2034)
Table 48. Global Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 49. Global Radiopharmaceutical Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Radiopharmaceutical Sales by Application (2018-2024) & (M Doses)
Table 51. Global Radiopharmaceutical Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Radiopharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Radiopharmaceutical Sales Market Share in Value by Application (2018-2024)
Table 54. Global Radiopharmaceutical Price by Application (2018-2024) & (USD/Dose)
Table 55. Global Radiopharmaceutical Sales by Application (2024-2034) & (M Doses)
Table 56. Global Radiopharmaceutical Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Radiopharmaceutical Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Radiopharmaceutical Sales Market Share in Value by Application (2024-2034)
Table 59. Global Radiopharmaceutical Price by Application (2024-2034) & (USD/Dose)
Table 60. North America Radiopharmaceutical Sales by Application (2018-2024) (M Doses)
Table 61. North America Radiopharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Radiopharmaceutical Sales by Application (2018-2024) (M Doses)
Table 63. Europe Radiopharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Radiopharmaceutical Sales by Application (2018-2024) (M Doses)
Table 65. Asia-Pacific Radiopharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Radiopharmaceutical Sales by Application (2018-2024) (M Doses)
Table 67. Latin America Radiopharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Radiopharmaceutical Sales by Application (2018-2024) (M Doses)
Table 69. Middle East and Africa Radiopharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Radiopharmaceutical Sales by Country (2018-2024) & (M Doses)
Table 71. North America Radiopharmaceutical Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Radiopharmaceutical Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Radiopharmaceutical Sales Market Share in Value by Country (2018-2024)
Table 74. North America Radiopharmaceutical Sales by Country (2024-2034) & (M Doses)
Table 75. North America Radiopharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Radiopharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Radiopharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Radiopharmaceutical Sales by Country (2018-2024) & (M Doses)
Table 79. Europe Radiopharmaceutical Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Radiopharmaceutical Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Radiopharmaceutical Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Radiopharmaceutical Sales by Country (2024-2034) & (M Doses)
Table 83. Europe Radiopharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Radiopharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Radiopharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Radiopharmaceutical Sales by Region (2018-2024) & (M Doses)
Table 87. Asia-Pacific Radiopharmaceutical Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Radiopharmaceutical Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Radiopharmaceutical Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Radiopharmaceutical Sales by Region (2024-2034) & (M Doses)
Table 91. Asia-Pacific Radiopharmaceutical Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Radiopharmaceutical Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Radiopharmaceutical Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Radiopharmaceutical Sales by Country (2018-2024) & (M Doses)
Table 95. Latin America Radiopharmaceutical Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Radiopharmaceutical Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Radiopharmaceutical Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Radiopharmaceutical Sales by Country (2024-2034) & (M Doses)
Table 99. Latin America Radiopharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Radiopharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Radiopharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Radiopharmaceutical Sales by Country (2018-2024) & (M Doses)
Table 103. Middle East and Africa Radiopharmaceutical Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Radiopharmaceutical Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Radiopharmaceutical Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Radiopharmaceutical Sales by Country (2024-2034) & (M Doses)
Table 107. Middle East and Africa Radiopharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Radiopharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Radiopharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 110. Bracco Imaging Company Information
Table 111. Bracco Imaging Introduction and Business Overview
Table 112. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 113. Bracco Imaging Radiopharmaceutical Product
Table 114. Bracco Imaging Recent Development
Table 115. Bayer Company Information
Table 116. Bayer Introduction and Business Overview
Table 117. Bayer Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 118. Bayer Radiopharmaceutical Product
Table 119. Bayer Recent Development
Table 120. Mallinckrodt Company Information
Table 121. Mallinckrodt Introduction and Business Overview
Table 122. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 123. Mallinckrodt Radiopharmaceutical Product
Table 124. Mallinckrodt Recent Development
Table 125. Nordion Company Information
Table 126. Nordion Introduction and Business Overview
Table 127. Nordion Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 128. Nordion Radiopharmaceutical Product
Table 129. Nordion Recent Development
Table 130. Triad Isotopes Company Information
Table 131. Triad Isotopes Introduction and Business Overview
Table 132. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 133. Triad Isotopes Radiopharmaceutical Product
Table 134. Triad Isotopes Recent Development
Table 135. Lantheus Company Information
Table 136. Lantheus Introduction and Business Overview
Table 137. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 138. Lantheus Radiopharmaceutical Product
Table 139. Lantheus Recent Development
Table 140. IBA Group Company Information
Table 141. IBA Group Introduction and Business Overview
Table 142. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 143. IBA Group Radiopharmaceutical Product
Table 144. IBA Group Recent Development
Table 145. GE Healthcare Company Information
Table 146. GE Healthcare Introduction and Business Overview
Table 147. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 148. GE Healthcare Radiopharmaceutical Product
Table 149. GE Healthcare Recent Development
Table 150. China Isotope & Radiation Company Information
Table 151. China Isotope & Radiation Introduction and Business Overview
Table 152. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 153. China Isotope & Radiation Radiopharmaceutical Product
Table 154. China Isotope & Radiation Recent Development
Table 155. Jubilant Pharma Company Information
Table 156. Jubilant Pharma Introduction and Business Overview
Table 157. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 158. Jubilant Pharma Radiopharmaceutical Product
Table 159. Jubilant Pharma Recent Development
Table 160. Eli Lilly Company Information
Table 161. Eli Lilly Introduction and Business Overview
Table 162. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 163. Eli Lilly Radiopharmaceutical Product
Table 164. Eli Lilly Recent Development
Table 165. Advanced Accelerator Applications Company Information
Table 166. Advanced Accelerator Applications Introduction and Business Overview
Table 167. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 168. Advanced Accelerator Applications Radiopharmaceutical Product
Table 169. Advanced Accelerator Applications Recent Development
Table 170. SIEMENS Company Information
Table 171. SIEMENS Introduction and Business Overview
Table 172. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 173. SIEMENS Radiopharmaceutical Product
Table 174. SIEMENS Recent Development
Table 175. Dongcheng Company Information
Table 176. Dongcheng Introduction and Business Overview
Table 177. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 178. Dongcheng Radiopharmaceutical Product
Table 179. Dongcheng Recent Development
Table 180. Navidea Company Information
Table 181. Navidea Introduction and Business Overview
Table 182. Navidea Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 183. Navidea Radiopharmaceutical Product
Table 184. Navidea Recent Development
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Radiopharmaceutical Market Trends
Table 188. Radiopharmaceutical Market Drivers
Table 189. Radiopharmaceutical Market Challenges
Table 190. Radiopharmaceutical Market Restraints
Table 191. Radiopharmaceutical Distributors List
Table 192. Radiopharmaceutical Downstream Customers
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Radiopharmaceutical Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Radiopharmaceutical Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of Actinium-225
Figure 6. Global Actinium-225 Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of Lutetium-177
Figure 8. Global Lutetium-177 Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Product Picture of Radium-223
Figure 10. Global Radium-223 Sales YoY Growth (2018-2034) & (M Doses)
Figure 11. Product Picture of Holmium-166
Figure 12. Global Holmium-166 Sales YoY Growth (2018-2034) & (M Doses)
Figure 13. Product Picture of Other
Figure 14. Global Other Sales YoY Growth (2018-2034) & (M Doses)
Figure 15. Global Radiopharmaceutical Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Radiopharmaceutical Sales Market Share by Type in 2022 & 2034
Figure 17. North America Radiopharmaceutical Sales Market Share in Volume by Type in 2022
Figure 18. North America Radiopharmaceutical Sales Market Share in Value by Type in 2022
Figure 19. Europe Radiopharmaceutical Sales Market Share in Volume by Type in 2022
Figure 20. Europe Radiopharmaceutical Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Radiopharmaceutical Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Radiopharmaceutical Sales Market Share in Value by Type in 2022
Figure 23. Latin America Radiopharmaceutical Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Radiopharmaceutical Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Radiopharmaceutical Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Radiopharmaceutical Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceutical Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceutical Revenue in 2022
Figure 29. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Oncology
Figure 31. Global Oncology Sales YoY Growth (2018-2034) & (M Doses)
Figure 32. Product Picture of Cardiology
Figure 33. Global Cardiology Sales YoY Growth (2018-2034) & (M Doses)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2018-2034) & (M Doses)
Figure 36. Global Radiopharmaceutical Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Radiopharmaceutical Sales Market Share by Application in 2022 & 2034
Figure 38. North America Radiopharmaceutical Sales Market Share in Volume by Application in 2022
Figure 39. North America Radiopharmaceutical Sales Market Share in Value by Application in 2022
Figure 40. Europe Radiopharmaceutical Sales Market Share in Volume by Application in 2022
Figure 41. Europe Radiopharmaceutical Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Radiopharmaceutical Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Radiopharmaceutical Sales Market Share in Value by Application in 2022
Figure 44. Latin America Radiopharmaceutical Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Radiopharmaceutical Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Radiopharmaceutical Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Radiopharmaceutical Manufacturing Cost Structure
Figure 49. Radiopharmaceutical Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed